CEBPA and glioblastoma: Emerging preclinical evidence suggests that phytochemicals such as EGCG interfere with adipogenic transcriptional pathways mediated by PPARγ and C/EBPα, which contribute to metabolic reprogramming and the stabilization of stem-like phenotypes in GBM.